JW Jungwo Pharmaceutical Relaunches Painkiller 'Brephin S'

JW Pharmaceutical announced on the 4th that it will launch a renewed product of the liquid soft capsule pain reliever ‘Breffin S’ with a reduced formulation size.

Breffin S is a liquid soft capsule pain reliever that quickly suppresses various pains such as fever, pain, back pain, menstrual pain, and inflammation. Its main ingredient, ibuprofen, is a safe component with a low risk of gastrointestinal side effects such as abdominal pain or vomiting and hepatotoxicity, making it effective for rapid pain relief.

This renewal of ‘Breffin S’ follows the pain reliever and anti-inflammatory drug ‘Pain Angel Pro’ launched last October. The focus was on reducing the formulation size. The size was reduced by about 22% by weight to improve the ease of intake for adolescents, women, and the elderly. Along with this, the package design was changed from the typical horizontal design to a vertical design to add differentiation.

JW Pharmaceutical plans to sequentially carry out renewal work on the entire lineup of pain relievers, including ‘Pain Angel Ibu’ and ‘Pain Angel Sen,’ following this ‘Breffin S’ renewal.

A JW Pharmaceutical official said, “We conducted the formulation size reduction renewal for the entire lineup of pain relievers to improve the convenience of consumers who take multiple doses per day,” adding, “Through this consumer-centered renewal, we plan to strengthen our position in the pain reliever market.”

JW Pharmaceutical has a lineup of five types of pain relievers by ingredient, including Breffin S, ▲Pain Angel Pro (active ingredient dexibuprofen), ▲Pain Angel Sen (active ingredient naproxen), ▲Pain Angel Ibu (active ingredient ibuprofen), and ▲Pain Angel Lady (active ingredients ibuprofen and pharmabrom).

This content was produced with the assistance of AI translation services.